2024-01-012024-12-312024-12-31false11400119COSMETY LINE LTD2025-09-19falseiso4217:GBPxbrli:pure114001192023-12-31114001192024-12-31114001192024-01-012024-12-31114001192022-12-31114001192023-12-31114001192023-01-012023-12-3111400119bus:SmallEntities2024-01-012024-12-3111400119bus:AuditExempt-NoAccountantsReport2024-01-012024-12-3111400119bus:FullAccounts2024-01-012024-12-3111400119bus:PrivateLimitedCompanyLtd2024-01-012024-12-3111400119core:WithinOneYear2024-12-3111400119core:AfterOneYear2024-12-3111400119core:WithinOneYear2023-12-3111400119core:AfterOneYear2023-12-3111400119core:ShareCapital2024-12-3111400119core:SharePremium2024-12-3111400119core:RevaluationReserve2024-12-3111400119core:OtherReservesSubtotal2024-12-3111400119core:RetainedEarningsAccumulatedLosses2024-12-3111400119core:ShareCapital2023-12-3111400119core:SharePremium2023-12-3111400119core:RevaluationReserve2023-12-3111400119core:OtherReservesSubtotal2023-12-3111400119core:RetainedEarningsAccumulatedLosses2023-12-3111400119core:LandBuildings2024-12-3111400119core:PlantMachinery2024-12-3111400119core:Vehicles2024-12-3111400119core:FurnitureFittings2024-12-3111400119core:OfficeEquipment2024-12-3111400119core:NetGoodwill2024-12-3111400119core:IntangibleAssetsOtherThanGoodwill2024-12-3111400119core:ListedExchangeTraded2024-12-3111400119core:UnlistedNon-exchangeTraded2024-12-3111400119core:LandBuildings2023-12-3111400119core:PlantMachinery2023-12-3111400119core:Vehicles2023-12-3111400119core:FurnitureFittings2023-12-3111400119core:OfficeEquipment2023-12-3111400119core:NetGoodwill2023-12-3111400119core:IntangibleAssetsOtherThanGoodwill2023-12-3111400119core:ListedExchangeTraded2023-12-3111400119core:UnlistedNon-exchangeTraded2023-12-3111400119core:LandBuildings2024-01-012024-12-3111400119core:PlantMachinery2024-01-012024-12-3111400119core:Vehicles2024-01-012024-12-3111400119core:FurnitureFittings2024-01-012024-12-3111400119core:OfficeEquipment2024-01-012024-12-3111400119core:NetGoodwill2024-01-012024-12-3111400119core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3111400119core:ListedExchangeTraded2024-01-012024-12-3111400119core:UnlistedNon-exchangeTraded2024-01-012024-12-3111400119core:MoreThanFiveYears2024-01-012024-12-3111400119core:Non-currentFinancialInstruments2024-12-3111400119core:Non-currentFinancialInstruments2023-12-3111400119dpl:CostSales2024-01-012024-12-3111400119dpl:DistributionCosts2024-01-012024-12-3111400119core:LandBuildings2024-01-012024-12-3111400119core:PlantMachinery2024-01-012024-12-3111400119core:Vehicles2024-01-012024-12-3111400119core:FurnitureFittings2024-01-012024-12-3111400119core:OfficeEquipment2024-01-012024-12-3111400119dpl:AdministrativeExpenses2024-01-012024-12-3111400119core:NetGoodwill2024-01-012024-12-3111400119core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3111400119dpl:GroupUndertakings2024-01-012024-12-3111400119dpl:ParticipatingInterests2024-01-012024-12-3111400119dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3111400119core:ListedExchangeTraded2024-01-012024-12-3111400119dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3111400119core:UnlistedNon-exchangeTraded2024-01-012024-12-3111400119dpl:CostSales2023-01-012023-12-3111400119dpl:DistributionCosts2023-01-012023-12-3111400119core:LandBuildings2023-01-012023-12-3111400119core:PlantMachinery2023-01-012023-12-3111400119core:Vehicles2023-01-012023-12-3111400119core:FurnitureFittings2023-01-012023-12-3111400119core:OfficeEquipment2023-01-012023-12-3111400119dpl:AdministrativeExpenses2023-01-012023-12-3111400119core:NetGoodwill2023-01-012023-12-3111400119core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3111400119dpl:GroupUndertakings2023-01-012023-12-3111400119dpl:ParticipatingInterests2023-01-012023-12-3111400119dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-012023-12-3111400119core:ListedExchangeTraded2023-01-012023-12-3111400119dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-012023-12-3111400119core:UnlistedNon-exchangeTraded2023-01-012023-12-3111400119core:NetGoodwill2024-12-3111400119core:IntangibleAssetsOtherThanGoodwill2024-12-3111400119core:LandBuildings2024-12-3111400119core:PlantMachinery2024-12-3111400119core:Vehicles2024-12-3111400119core:FurnitureFittings2024-12-3111400119core:OfficeEquipment2024-12-3111400119core:AfterOneYear2024-12-3111400119core:WithinOneYear2024-12-3111400119core:ListedExchangeTraded2024-12-3111400119core:UnlistedNon-exchangeTraded2024-12-3111400119core:ShareCapital2024-12-3111400119core:SharePremium2024-12-3111400119core:RevaluationReserve2024-12-3111400119core:OtherReservesSubtotal2024-12-3111400119core:RetainedEarningsAccumulatedLosses2024-12-3111400119core:NetGoodwill2023-12-3111400119core:IntangibleAssetsOtherThanGoodwill2023-12-3111400119core:LandBuildings2023-12-3111400119core:PlantMachinery2023-12-3111400119core:Vehicles2023-12-3111400119core:FurnitureFittings2023-12-3111400119core:OfficeEquipment2023-12-3111400119core:AfterOneYear2023-12-3111400119core:WithinOneYear2023-12-3111400119core:ListedExchangeTraded2023-12-3111400119core:UnlistedNon-exchangeTraded2023-12-3111400119core:ShareCapital2023-12-3111400119core:SharePremium2023-12-3111400119core:RevaluationReserve2023-12-3111400119core:OtherReservesSubtotal2023-12-3111400119core:RetainedEarningsAccumulatedLosses2023-12-3111400119core:NetGoodwill2022-12-3111400119core:IntangibleAssetsOtherThanGoodwill2022-12-3111400119core:LandBuildings2022-12-3111400119core:PlantMachinery2022-12-3111400119core:Vehicles2022-12-3111400119core:FurnitureFittings2022-12-3111400119core:OfficeEquipment2022-12-3111400119core:AfterOneYear2022-12-3111400119core:WithinOneYear2022-12-3111400119core:ListedExchangeTraded2022-12-3111400119core:UnlistedNon-exchangeTraded2022-12-3111400119core:ShareCapital2022-12-3111400119core:SharePremium2022-12-3111400119core:RevaluationReserve2022-12-3111400119core:OtherReservesSubtotal2022-12-3111400119core:RetainedEarningsAccumulatedLosses2022-12-3111400119core:AfterOneYear2024-01-012024-12-3111400119core:WithinOneYear2024-01-012024-12-3111400119core:Non-currentFinancialInstrumentscore:CostValuation2024-01-012024-12-3111400119core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-012024-12-3111400119core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-012024-12-3111400119core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-012024-12-3111400119core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-012024-12-3111400119core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-012024-12-3111400119core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3111400119core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3111400119core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3111400119core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3111400119core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3111400119core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3111400119core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3111400119core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3111400119core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3111400119core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3111400119core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3111400119core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3111400119core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3111400119core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3111400119core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3111400119core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3111400119core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3111400119core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3111400119core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3111400119core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3111400119core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3111400119bus:Director12024-01-012024-12-31

COSMETY LINE LTD

Registered Number
11400119
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2024

COSMETY LINE LTD
Company Information
for the year from 1 January 2024 to 31 December 2024

Director

Ms C GONTA

Registered Address

58 Nyland Court
Naomi Street
London
SE8 5EW

Registered Number

11400119 (England and Wales)
COSMETY LINE LTD
Balance Sheet as at
31 December 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets311,3458,902
11,3458,902
Current assets
Stocks4274,375372,433
Debtors5112,930319,418
Cash at bank and on hand25,48931,744
412,794723,595
Creditors amounts falling due within one year6(386,456)(642,662)
Net current assets (liabilities)26,33880,933
Total assets less current liabilities37,68389,835
Provisions for liabilities7(2,155)-
Net assets35,52889,835
Capital and reserves
Called up share capital11
Profit and loss account35,52789,834
Shareholders' funds35,52889,835
The financial statements were approved and authorised for issue by the Director on 19 September 2025, and are signed on its behalf by:
Ms C GONTA
Director
Registered Company No. 11400119
COSMETY LINE LTD
Notes to the Financial Statements
for the year ended 31 December 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses. The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation. Depreciation Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Straight line (years)
Office Equipment4
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
Trade and other debtors
Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business. Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Trade creditors Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities. Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

20242023
Average number of employees during the year11
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 January 2416,45516,455
Additions6,9126,912
At 31 December 2423,36723,367
Depreciation and impairment
At 01 January 247,5537,553
Charge for year4,4694,469
At 31 December 2412,02212,022
Net book value
At 31 December 2411,34511,345
At 31 December 238,9028,902
4.Stocks

2024

2023

££
Finished goods274,375372,433
Total274,375372,433
5.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables109,662227,317
Other debtors3,26892,101
Total112,930319,418
Included in Trade Debtors is an amount due from Cosmety LLC (a company under joint control) at the balance sheet date of £23,307 (2013 £22,951).
6.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables306,229323,285
Bank borrowings and overdrafts85-
Amounts owed to related parties4,060179,693
Taxation and social security32,29969,712
Other creditors-60,619
Accrued liabilities and deferred income43,7839,353
Total386,456642,662
In addition to the amounts due to Cosmety LLC included in "Amounts owed to related parties" noted above, included in Trade creditors the following balances with companies under joint control subsisted at the balance sheet date: Cosmety LLC: £76,439 (2013 £58,218) Plantifique Skincare SRL £339 (2013 £99)
7.Provisions for liabilities

2024

2023

££
Other provisions2,155-
Total2,155-
8.Related party transactions
All transactions with related parties are conducted at arms length and the amounts due to and from related parties are shown under the debtors and creditors notes.